BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86%
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note
Section:
 

Relative Value

The Relative Value of one BNN stock under the Base Case scenario is 4.61 EUR. Compared to the current market price of 3.44 EUR, BRAIN Biotech AG is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNN Relative Value
Base Case
4.61 EUR
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
92
vs Industry
62
Median 3Y
1.9
Median 5Y
3.4
Industry
1.5
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-14.8
Median 5Y
-16.7
Industry
21.7
Forward
-9.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-37.9
Median 5Y
-33.1
Industry
13
More Details
6.2
P/FCFE
P/FCFE
Price to FCFE
6.2
vs History
11
vs Industry
53
Median 3Y
-16.4
Median 5Y
-19.8
Industry
20.5
More Details
4.1
P/B
P/B
Price to Book Value
4.1
vs History
77
vs Industry
24
Median 3Y
4.2
Median 5Y
4.4
Industry
1.6
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
92
vs Industry
69
Median 3Y
2.1
Median 5Y
3.4
Industry
1.6
Forward
1.2
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
92
vs Industry
86
Median 3Y
3.6
Median 5Y
5.9
Industry
7.2
More Details
56.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
56.8
vs History
15
vs Industry
20
Median 3Y
-14.5
Median 5Y
-20.1
Industry
13.2
Forward
63.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-21.2
Industry
17.5
Forward
-40
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-34.6
Median 5Y
-33
Industry
13.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-16.9
Median 5Y
-19.9
Industry
19.1
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
77
vs Industry
68
Median 3Y
1.7
Median 5Y
1.9
Industry
1.3
More Details

Multiples Across Competitors

BNN Competitors Multiples
BRAIN Biotech AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
BRAIN Biotech AG
XETRA:BNN
75.2m EUR 1.3 -8.6 56.8 -12
US
Sherwin-Williams Co
NYSE:SHW
86.9B USD 3.8 34 22 25.6
US
Ecolab Inc
NYSE:ECL
68B USD 4.3 33.3 21.2 28.9
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.2T JPY 4.1 20 8.9 11.6
CH
Givaudan SA
SIX:GIVN
36.4B CHF 5.1 35.3 24.7 31.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
234.5B CNY 1.2 15.4 16.8 16.8
US
Dupont De Nemours Inc
NYSE:DD
32.1B USD 2.6 40.2 12.6 21
US
PPG Industries Inc
NYSE:PPG
27.9B USD 1.5 18.8 11.4 14.1
CH
DSM-Firmenich AG
AEX:DSFIR
25.9B EUR 2.4 12.2 30.8 -60.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.3 47.9 32.5 37.7
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
P/E Multiple
Earnings Growth P/E to Growth
DE
BRAIN Biotech AG
XETRA:BNN
Average P/E: 31.2
Negative Multiple: -8.6 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
34
52%
0.6
US
Ecolab Inc
NYSE:ECL
33.3
76%
0.4
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
20
40%
0.5
CH
Givaudan SA
SIX:GIVN
35.3
46%
0.8
CN
Wanhua Chemical Group Co Ltd
SSE:600309
15.4
41%
0.4
US
Dupont De Nemours Inc
NYSE:DD
40.2
399%
0.1
US
PPG Industries Inc
NYSE:PPG
18.8
80%
0.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
12.2
-42%
N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
47.9
7%
6.6
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
BRAIN Biotech AG
XETRA:BNN
Average EV/EBITDA: 24.2
56.8
474%
0.1
US
Sherwin-Williams Co
NYSE:SHW
22
27%
0.8
US
Ecolab Inc
NYSE:ECL
21.2
38%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
8.9
36%
0.2
CH
Givaudan SA
SIX:GIVN
24.7
34%
0.7
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.8
131%
0.1
US
Dupont De Nemours Inc
NYSE:DD
12.6
32%
0.4
US
PPG Industries Inc
NYSE:PPG
11.4
21%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
30.8
203%
0.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
32.5
10%
3.2
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
BRAIN Biotech AG
XETRA:BNN
Average EV/EBIT: 25
Negative Multiple: -12 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
25.6
34%
0.7
US
Ecolab Inc
NYSE:ECL
28.9
52%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.6
N/A N/A
CH
Givaudan SA
SIX:GIVN
31.5
44%
0.7
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.8
39%
0.4
US
Dupont De Nemours Inc
NYSE:DD
21
83%
0.3
US
PPG Industries Inc
NYSE:PPG
14.1
28%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
Negative Multiple: -60.2 N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
37.7
5%
7.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A

See Also

Summary
BNN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNN stock valuation using valuation multiples.
Wall Street Estimates
BNN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.